LBL-033

· Nanjing Leads Biolabs Co., Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LBL-033, covering 2025-05-07 to 2025-05-07. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I/II Clinical Trial of LBL-033 in the Treatment of Advanced Malignant Tumors [Phase 1, Phase 2]